<DOC>
	<DOCNO>NCT02171455</DOCNO>
	<brief_summary>To assess safety , pharmacokinetics effect dabigatran coagulation parameter prior administration high dose dabigatran etexilate QT study</brief_summary>
	<brief_title>Safety , Pharmacodynamics Pharmacokinetics After Single Oral Administration Dabigatran Etexilate Capsule Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Dabigatran</mesh_term>
	<criteria>1 . Healthy male accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( blood pressure ( BP ) , pulse rate ( PR ) ) , 12lead electrocardiogram ( ECG ) , clinical laboratory test 2 . Age ≥18 ≤55 year 3 . Body Mass Index ( BMI ) ≥18.5 BMI ≤29.9 kg/m2 4 . Signed date write informed consent prior admission study accordance GCP ( Good Clinical Practice ) local legislation . 1 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 2 . Relevant surgery gastrointestinal tract 3 . History bleed disorder acute blood coagulation defect 4 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 5 . History relevant orthostatic hypotension , faint spell blackouts 6 . Chronic relevant acute infection 7 . History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator 8 . Intake drug long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration trial 9 . Use drug might reasonably influence result trial base knowledge time protocol preparation within 10 day prior administration trial 10 . Participation another trial investigational drug within two month prior administration trial 11 . Alcohol abuse ( 60 g/day ) 12 . Drug abuse 13 . Blood donation ( 100 mL within four week prior administration trial ) 14 . Excessive physical activity ( within one week prior administration trial ) 15 . Any laboratory value outside reference range clinical relevance 16 . Inability comply dietary regimen study centre</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>